Updated Management Guidelines for Adenosine Deaminase Deficiency.

Grunebaum, Eyal; Booth, Claire; Cuvelier, Geoffrey D E; Loves, Robyn; Aiuti, Alessandro; Kohn, Donald B

Grunebaum, Eyal; Booth, Claire; Cuvelier, Geoffrey D E; Loves, Robyn; Aiuti, Alessandro; Kohn, Donald B.

Affiliation

Grunebaum E; Division of Immunology and Allergy, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: eyal.grunebaum@sickkids.ca.
Booth C; Department of Paediatric Immunology and Gene Therapy, Great Ormond Street Hospital, London, United Kingdom.
Cuvelier GDE; Manitoba Blood and Marrow Transplant Program, CancerCare Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.
Loves R; Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Aiuti A; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, and the Università Vita-Salute San Raffaele, Milan, Italy.
Kohn DB; Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, Calif.

J Allergy Clin Immunol Pract ; 11(6): 1665-1675, 2023 06.

Article in En | MEDLINE | ID: mdl-36736952

Subject(s)
Key words

Adenosine deaminase deficiency; Enzyme replacement; Gene therapy; Management; Severe combined immunodeficiency; Transplantation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Severe Combined Immunodeficiency / Hematopoietic Stem Cell Transplantation / Agammaglobulinemia Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Limits: Humans / Infant / Newborn Language: En Journal: J Allergy Clin Immunol Pract Year: 2023 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google